AE-3763 is a peptide-based inhibitor of human neutrophil elastase with an IC50 of 29 nM; it exhibits potent in vitro inhibitory activity against human neutrophil elastase, high aqueous solubility, and stability; in vivo, it significantly inhibits lung edema and leukocyte infiltration, improves survival rate in a mouse model of fatal shock associated with multiple organ dysfunction, and dose-dependently prevents hemorrhage when administered intravenously by infusion (ED50: 0.42 mg/kg/h) or bolus injection (1.2 mg/kg).